Risk factors

Expeditors relies heavily on third-party air, ocean, and ground carriers for non-asset-based global logistics operations.

First American Financial Corp is heavily exposed to real estate market fluctuations, interest rate changes, and economic conditions. Title insurance operations face extensive state regulation, reliance on independent title agents, and investment portfolio risks.

First Citizens Bancshares faces dominant risks from credit portfolio concentrations, interest rate sensitivity, regulatory compliance, and liquidity pressures.

First Financial Bankshares faces intense geographic concentration risk in Texas and significant regional economic exposure. The bank relies heavily on net interest income, wealth management fees, and small-to-medium business lending. Operations are also exposed to commercial real estate collateral values, severe weather events, and stringent regulatory compliance.

Five9 faces profitability risks with an accumulated deficit of $417.6 million as of December 31, 2024. Growth depends heavily on expanding AI solutions to offset potential declines in traditional license revenues. The company relies on key third-party integrations and public cloud infrastructure to deliver its contact center software.

FormFactor relies heavily on probe card sales to a concentrated group of foundry, logic, and memory customers. International sales, particularly in China and Germany, expose the business to geopolitical trade tensions and currency fluctuations. Semiconductor industry cyclicality and customer test strategy shifts drive significant revenue and inventory volatility.

Fortinet faces intense cybersecurity competition and relies heavily on international sales and channel partners. Rapid technological shifts, including AI integration and cloud service expansion, create new operational and security risks. Strict regulatory compliance, trade controls, and complex product development heavily impact ongoing financial results.

GCM Grosvenor faces heavy competition across investment performance, terms, and reputation to attract capital and talent.

Genuine Parts Co relies heavily on automotive and industrial parts demand, vehicle mileage, and total car parc population.

GT Biopharma faces critical going concern doubt with only $4.0 million in cash against a $1.7 million working capital deficit. The company has a history of operating losses totaling $695 million and no product revenue. Operations depend heavily on outsourced manufacturers, third-party licenses, and a tiny team of one full-time employee plus consultants.

Investment portfolio and insurance operations face economic volatility, interest rate shifts, and severe inflation impacts on claim costs.

Concentration of sales among a very small number of OEM customers dominates the risk profile.